Hong Soon. Kang, et.al., Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance., Diabetes, 2011, 60

http://rdf.ncbi.nlm.nih.gov/pubmed/20864514

Hong Soon. Kang, et.al., Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance., Diabetes, 2011, 60

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD43752
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD43752

allele

http://purl.org/net/cito/citesAsAuthority

• Nr2c2<tm1Amj>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4941026

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased epididymal fat pad weight_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0009289B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased brown adipose tissue mass_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0014169B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased circulating aspartate transaminase level_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0005632B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased susceptibility to hepatic steatosis_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0002310B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• increased respiratory quotient_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0010378B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• abnormal eating behavior_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0001431B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased circulating triglyceride level_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0002644B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased circulating glucose level_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0005560B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased abdominal fat pad weight_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0009287B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• abnormal glucose homeostasis_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0002078B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased circulating insulin level_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0002727B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• increased carbon dioxide production_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0008963B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased circulating alanine transaminase level_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0002942B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• abnormal lipid homeostasis_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0002118B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased inflammatory response_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0001876B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased body fat mass_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0014143B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased susceptibility to diet-induced obesity_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0005659B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• increased energy expenditure_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0004889B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• abnormal blood homeostasis_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0009642B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased liver triglyceride level_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0009356B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• increased oxygen consumption_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0005289B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• embryonic lethality during organogenesis, incomplete penetrance_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0011108B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• abnormal gas homeostasis_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0003948B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• abnormal white adipose tissue physiology_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0005670B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased circulating cholesterol level_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0005179B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased white fat cell size_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0009133B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• abnormal energy homeostasis_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0005448B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased circulating LDL cholesterol level_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0000183B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj
• decreased body weight_Nr2c2<tm1Amj>/Nr2c2<tm1Amj>
  http://metadb.riken.jp/0001262B6129Nr2c2tm1AmjNr2c2tm1AmjNr2c2tm1AmjNr2c2tm1Amj